Skip to content
Biodatica
Start free

Shanghai Proton and Heavy Ion Center

Shanghai, Shanghai Municipality

OncologyPhase III
Compare Sign in to watch

What changed

Phase III trial registered: Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1

5w agoTrial registeredJun 11, 2026Source filing (opens the source filing in a new tab)

Momentum

80no change

Momentum 80 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase III

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

368 pre-ticker oncology companies at Phase III

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE2 registered

    Jul 1, 2025

    Thymic Epithelial Tumor, Radiotherapy Side Effect, Carbon Ion Radiotheray, Heavy Ion Radiotherapy · RECRUITING · sponsor: Jian Chen · Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor

    ClinicalTrials.gov · NCT06311955 (opens the source filing in a new tab)

  2. Trial

    PHASE2 registered

    Sep 29, 2024

    Non-small Cell Lung Cancer · RECRUITING · sponsor: Shanghai Proton and Heavy Ion Center · Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer

    ClinicalTrials.gov · NCT05613452 (opens the source filing in a new tab)

  3. Trial

    PHASE2 registered

    Jan 26, 2024

    Carbon Ion Radiotherapy, Thymoma, Thymic Carcinoma, Radiotherapy, Chemotherapy · RECRUITING · sponsor: Jian Chen · Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors

    ClinicalTrials.gov · NCT06186726 (opens the source filing in a new tab)

  4. Trial

    PHASE3 registered

    Mar 1, 2023

    Locally Advanced Gastric Carcinoma · RECRUITING · sponsor: Zhejiang University · Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1

    ClinicalTrials.gov · NCT05593458 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources